| 000 | 01108naa a22002897u 4500 | ||
|---|---|---|---|
| 001 | 04518 | ||
| 003 | HDC | ||
| 007 | cr bn ---aaaaa | ||
| 008 | 210117t2008 flu bi 001 0 eng | ||
| 020 | _a0849390060 | ||
| 020 |
_a9780849390067 _q(hardcover) |
||
| 040 | _aHDC | ||
| 082 |
_aRS403.C424 2007 _b615.19 |
||
| 245 | 0 |
_aCHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. _nChapter 17 : _bLNA (Locked Nucleic Acid) and Functionalized LNA: Toward Efficient Gene Targeting / _ceditors, E. A. Rekka and P. N. Kourounakis |
|
| 260 |
_aBoca Raton, Florida : _bCRC Press, _c©2008 |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 650 |
_aDrugs _xDesign _94602 |
||
| 650 |
_aPharmaceutical chemistry _94601 |
||
| 700 |
_aKourounakis, P. N., _eeditor _94604 |
||
| 700 |
_aRekka, E. A., _eeditor _94603 |
||
| 856 | _zRequest full-text at [email protected] | ||
| 942 | _2lcc | ||
| 942 | _cCHAP | ||
| 942 | _kEBCH 000885 | ||
| 999 |
_c1843 _d1843 |
||